Africa CDC Director General Visits SK bioscience to Discuss Vaccine Localization in Africa

SK bioscience Benin Burkina Faso Burundi Cameroon Chad Comoros Cote d'Ivoire Djibouti Ethiopia Gabon Gambia Ghana Guinea Equatorial Guinea Kenya Liberia Madagascar Mali Namibia Niger Nigeria Central African Republic Congo, The Democratic Republic of the Congo, The Republic of the Senegal Sierra Leone South Africa Sudan Tanzania Tonga Uganda Zambia Zimbabwe Algeria Angola Botswana Cape Verde Egypt Eritrea Guinea-Bissau Lesotho Libya Malawi Mauritania Mauritius Morocco Mozambique Rwanda Sao Tome and Principe Seychelles South Sudan Swaziland Togo Tunisia South Korea

H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Africa CDC), visited SK bioscience to discuss the vaccine localization program in the African continent.SK bioscience introduced the 'Glocalization Project' which is transplanting R&D and manufacturing capabilities to countries that lack sufficient vaccine infrastructures. View original content:https://www.prnewswire.co.uk/news-releases/africa-cdc-director-general-visits-sk-bioscience-to-discuss-vaccine-localization-in-africa-301977822.html